Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis
Part of paid clinical trials in Charlottesville, Virginia.
- Sponsor
- Fuller Research Foundation
- Study ID
- NCT07524244
- Status
- Recruiting
Conditions
- Crohn's Disease (CD)
- Rheumatoid Arthritis (RA)
- Ulcerative Colitis (UC)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 64 Years
- Healthy Volunteers
- Not accepted
Interventions
- Ketogenic diet — BEHAVIORALThe ketogenic diet is a high fat, moderate protein, and very low carbohydrate nutritional approach designed to shift the body's primary energy source from glucose to ketones, compounds produced in the liver from fat metabolism. This state of nutritional ketosis typically occurs when carbohydrate intake is restricted to 20-50 grams per day, though the exact threshold varies based on individual factors such as muscle mass, insulin sensitivity, and physical activity. Participants will receive nutritional guidance for the ketogenic diet in a virtual setting via both synchronous and asynchronous engagement including group telehealth sessions, dietary education guides/food lists, quantitative sample meals plans and ongoing messaging capacity with the clinical team for the duration of the dietary intervention.
- Carnivore (Lion) Diet — BEHAVIORALThe carnivore (lion) diet is a more restrictive form of a ketogenic diet that is intended as an elimination dietary protocol composed exclusively of ruminant meats (beef, lamb, bison, venison, goat, moose, elk), salt, and water. A broader carnivore diet includes more animal foods such as additional meats, fish, eggs, and some dairy. It excludes, however, all plant foods including vegetables, fruits, grains, legumes, nuts, seeds, or plant-derived oils. Participants will receive nutritional guidance for the carnivore (lion) and the broader carnivore diet in a virtual setting via both synchronous and asynchronous engagement including group telehealth sessions, dietary education guides/food lists, quantitative sample meals plans and ongoing messaging capacity with the clinical team for the duration of the dietary intervention.
Study Details
This study is a randomized controlled clinical trial evaluating whether two therapeutic dietary approaches - a ketogenic diet and a carnivore (lion) diet - can improve quality of life, reduce symptoms, and influence measures of disease activity in adults with inflammatory bowel disease \[ulcerative colitis and Crohn's disease\] (IBD) or rheumatoid arthritis (RA). Participants will be randomized into one of three groups: 1) Ketogenic Diet, 2) Carnivore (Lion) Diet or 3) Wait-List Control. Participants randomized to a dietary group (ketogenic diet or carnivore diet) will be provided guidance on their specific dietary therapy and answer questions about their symptoms and quality of life at different intervals over a 24 week period. Participants will also complete laboratory testing at different intervals to assess for changes in nutritional status, cardiometabolic health and markers of immune activation and inflammation. Participants initially placed on the wait-list group will be asked similar questions about their symptoms and quality of life and complete the same laboratory testing as participants in a dietary group. Participants on the wait list will then be compared to participants following a specific dietary pattern to assess for any differences between the 2 groups. After 12 weeks, participants on the wait list will be randomized to a dietary group (ketogenic diet or carnivore diet) and followed in a similar fashion for an additional 12 week period.
Key Dates
- Start date
- Feb 17, 2026
- Status verified
- Apr 2026
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Ketogenic Diet 24 WeeksParticipants with IBD or RA randomized initially to receive dietary counseling regarding the ketogenic diet for up to 24 weeks
- Experimental: Carnivore (Lion) Diet 24 WeeksParticipants with IBD or RA randomized initially to receive dietary counseling regarding the carnivore (lion) diet for up to 24 weeks
- No Intervention: Wait List 12 WeeksParticipants with IBD or RA randomized initially to a 12 week waitlist who will continue their baseline dietary pattern WITHOUT specific dietary guidance/intervention
- Experimental: Carnivore (Lion) Diet for 12 weeks AFTER Wait-ListParticipants with IBD or RA randomized initially to the wait-list for 12 weeks who are then randomized to receive dietary counseling regarding the carnivore (lion) diet for a subsequent 12 weeks
- Experimental: Ketogenic Diet for 12 Weeks AFTER Wait-ListParticipants with IBD or RA randomized initially to the wait-list for 12 weeks who are then randomized to receive dietary counseling regarding the carnivore (lion) diet for a subsequent 12 weeks
- Experimental: Voluntary Crossover - Ketogenic Diet to Carnivore (Lion) Diet AFTER 12 weeksParticipants with IBD or RA randomized initially to the ketogenic diet for 12 weeks who voluntarily choose to crossover to the carnivore (lion) diet intervention for the final 12 weeks
- Experimental: Voluntary Crossover - Carnivore (Lion) Diet to Ketogenic Diet AFTER 12 weeksParticipants with IBD or RA randomized initially to the carnivore (lion) diet for 12 weeks who voluntarily choose to crossover to the ketogenic diet intervention for the final 12 weeks
Primary Outcome Measure
Change in health-related quality of life measured using the 36-Item Short Form Health Survey (SF-36) [ Time Frame: From baseline to 24 weeks ]
Central Contacts
- Robert D Abbott, MD4342183425
- Emily Palmer, MS, CNS
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Resilient Roots: Functional Medicine | Charlottesville | Virginia | 22901 | Robert D Abbott, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Charlottesville, VA
Related Studies
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)PHASE3 · Recruiting · Takeda · Phoenix, Arizona
- Study of XmAb942 in Healthy Participants and Participants With Ulcerative ColitisPHASE1/PHASE2 · Recruiting · Xencor, Inc. · Scottsdale, Arizona
- LY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisPHASE2 · Recruiting · Eli Lilly and Company · Phoenix, Arizona
- Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD)Recruiting · Yale University · New Haven, Connecticut